Table 3 Antihypertensive medication and therapeutic intensity score (TIS) V3 and V12

From: Blood pressure control, hypertension phenotypes, and albuminuria: outcomes of the comprehensive Basel Postpartum Hypertension Registry

 

Full Cohort

(n = 370)

Preeclampsia, eclampsia, HELLP

(n = 205)

HDP, CH and de novo PPHT excluding PE, eclampsia and HELLP

(n = 165)

p value

V3 n (%)

Antihypertensive medication

46/239 (19.2%)

20/131 (15.3)

26/108 (24.1)

0.086

V3 TIS

mean (SD)

median (IQR)

0.7 (±0.6)

0.5 (0.3–1.0)

0.6 (±0.5)

0.5 (0.3–0.9)

0.8 (±0.7)

0.5 (0.3–1.4)

0.812

V12 n (%)

Antihypertensive medication

21/105 (20%)

5/54 (9.3%)

16/51 (31.4%)

0.005

V12 TIS

mean (SD)

median (IQR)

0.6 (±0.4)

0.5 (0.3–1.0)

0.6 (±0.4)

0.5 (0.1–1.0)

0.6 (±0.4)

0.5 (0.3–1.0)

0.386

  1. Data presented as mean (±SD), median (IQR); n (%)
  2. Mean(±SD) compared using the unpaired t-test
  3. Median interquartile range (IQR) Mann-Whitney-U-Test
  4. p values are shown next to means or medians based on the appropriate distribution
Back to article page